Astellas Builds Up Antibodies Pipeline
By Business Review Editor
Pharma Deals Review: Vol 2008 Issue 91 (Table of Contents)
Published: 1 Jan-2008
DOI: 10.3833/pdr.v2008.i91.233 ISSN: 1756-7874
Section: Features
Fulltext:
Abstract
Biologics, in particular antibodies, are playing an increasingly important part in the R&D of big pharma, and it is to be expected that all of the major global players want in...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS